Eprex-associated pure red cell aplasia and leachates
- 1 June 2006
- journal article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 24 (6), 613-614
- https://doi.org/10.1038/nbt0606-613
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interaction of Polysorbate 80 with Erythropoietin: A Case Study in Protein–Surfactant InteractionsPharmaceutical Research, 2005
- The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringesKidney International, 2005
- Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mysteryNephrology Dialysis Transplantation, 2005
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- Micelle-Associated Protein in Epoetin Formulations: A Risk Factor for Immunogenicity?Pharmaceutical Research, 2003
- Bioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery, 2002
- Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell AplasiaNew England Journal of Medicine, 1996
- The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse modelDiabetologia, 1994